AIM
BNGO icon

Aigen Investment Management’s Bionano Genomics BNGO Stock Holding History

Aigen Investment Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25
Closed -$16.7K – 755
2023
Q1 		$16.7K Buy
+25
New +$22.2K ﹤0.01% 592

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aigen Investment Management's BNGO Position: Q2 2023 in Review

Aigen Investment Management sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 25 shares — an estimated $16.7K sold.

Aigen Investment Management first reported a position in BNGO in Q1 2023 and held it in 1 quarter. The position peaked at $16.7K in Q1 2023. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Aigen Investment Management reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Aigen Investment Management sold 25 Bionano Genomics shares in Q2 2023, an estimated $16.7K.
  • Aigen Investment Management first reported a position in Bionano Genomics in Q1 2023 and held it in 1 quarter.
  • Aigen Investment Management's Bionano Genomics position peaked at $16.7K in Q1 2023.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Aigen Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.